Small Peptide Inhibitor of JNK3 Protects Dopaminergic Neurons from MPTP Induced Injury via Inhibiting the ASK1-JNK3 Signaling Pathway-Reference-Cited by-同舟云学术

Small Peptide Inhibitor of JNK3 Protects Dopaminergic Neurons from MPTP Induced Injury via Inhibiting the ASK1-JNK3 Signaling Pathway

Published:2015-04-09 Issue:4 Volume:10 Page:e0119204
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pan Jing,Li Hui,Zhang Bei,Xiong Ran,Zhang Yu,Kang Wen-Yan,Chen Wei,Zhao Zong-Bo,Chen Sheng-Di

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group;MC de Rijk;Neurology,2000

2. Where does parkinson disease pathology begin in the brain?;K Del Tredici;J Neuropathol Exp Neurol,2002

3. Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease;J Pan;Neurochem Int,2009

4. JNK3 mediates paraquat- and rotenone-induced dopaminergic neuron death;WS Choi;J Neuropathol Exp Neurol,2010

5. Targeting JNK3 for the treatment of neurodegenerative disorders;L Resnick;Drug Discov Today,2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

2. JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties;Cell Adhesion & Migration;2024-02-15

3. The Function of ASK1 in Sepsis and Stress-Induced Disorders;International Journal of Molecular Sciences;2023-12-22

4. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease;J MED CHEM;2023

5. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson’s Disease;Journal of Medicinal Chemistry;2023-01-17